AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today.
Worldwide net revenues rose 59.2% year-over-year to $13.8 billion on a reported basis. On an operational basis, sales rose 6.8%.
Net earnings attributable to AbbVie were $36 million, or $0.01 per share, compared to $2.8 billion, or $1.88 per share, last year. The GAAP results included a non-cash charge for Skyrizi contingent consideration revaluation based on higher estimated future sales. Adjusted EPS totaled $2.92.
Both revenue and earnings surpassed market projections.
For the full year of 2021, GAAP EPS is expected to be $6.69-6.89 and adjusted EPS is expected to be $12.32-12.52.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results
The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.
YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results
Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,
